Tibial Fractures: Clinical Trials

4 trials for Tibial Fractures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Tibial Fractures: new trials by email Literature Review of Tibial Fractures trials Research Report on Tibial Fractures

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures
Intravenous ketorolac and oral acetaminophen, Intravenous morphine and oral oxycodone - Femur Fracture, Tibial Fractures
Phase 4CompletedUniversity of Puerto Rico1672021-04-182025-03-04
Efficacy Study of Surgical Technique in Intramedullary Tibia Nailing, Using Trigen META Tibia Nails
Semi-extended Surgical Technique, Standard Surgical Technique - Tibial Fractures
Phase 4CompletedSmith & Nephew Orthopaedics AG952011-02-012016-06-17
Study Evaluating InductOs in Diaphyseal Tibia Fractures
InductOs - Tibial Fractures
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer2772003-09-012009-09-07
The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
Low Molecular Weight Heparin (dalteparin) - Deep Vein Thrombosis, Pulmonary Embolism
Phase 4CompletedSunnybrook Health Sciences Centre7002002-08-012007-02-27

Narrower conditions

Femoral Fractures (1)  ·  Pain, Postoperative (1)  ·  Pulmonary Embolism (1)  ·  Thrombosis (1)  ·  Venous Thrombosis (1)

Broader conditions

Fractures, Bone (4)  ·  Leg Injuries (4)  ·  Wounds and Injuries (4)  ·  Cardiovascular Diseases (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Lung Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Respiratory Tract Diseases (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Acetaminophen (1)  ·  Bone Morphogenetic Protein 2 (1)  ·  Dalteparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Oxycodone (1)

Sponsors

Smith & Nephew Orthopaedics AG (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  University of Puerto Rico (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

Germany (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  South Africa (1)

Top investigators

Alan Johnstone, Professor (1)  ·  Daren Forward, MA, FRCS, DM (1)  ·  Ismael Escriba, Dr. (1)  ·  Luis F. Lojo-Sojo, MD (1)  ·  Markus Graf, Dr. (1)  ·  Pedro Caba, Dr. (1)  ·  Rita Selby, MBBS, FRCPC (1)  ·  William Geerts, MD, FRCPC (1)

Results publications

PMID 25900749, PMID 38579315